S1QEL effectively suppresses both glycolytic reprogramming and pro-inflammatory cytokine expression induced by OxLDL in human monocytes, underscore the role of mitochondrial complex I-derived ROS in monocyte activation and highlight S1QEL as a potential therapeutic agent for targeting inflammation in aging and several...
Negin Mosalmanzadeh, R. Maurmann, K. Davis et al.· Immunometabolism· 0 citations
This review integrates epidemiologic and mechanistic evidence linking obesity and metabolic dysfunction to EOCs, with a focus on colorectal and breast cancers, and highlights key biological pathways, including metabolic signaling, inflammation, microbiome alterations, endocrine disruption, and epigenetic reprogramming.
Mansi Upadhyay, Arianna V. Bastian, T. Cardaci et al.· Carcinogenesis· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.